North America Organ Preservation Market

North America Organ Preservation Market Size & Growth (2023 to 2028)

The Size of the North America Organ Preservation Market was valued at USD 95.77 million in 2023 and estimated to grow at a CAGR of 9%, to reach USD 147.35 million by 2028 during the forecast period 2023 to 2028.

Rising number of cases of organ failure in North America, demand is on the rise. In addition, the increasing incidence of organ failure and the growing amount of organ transplant surgeries in North America are driving the market forward.

Over the previous three decades, one of the main factors in Cardiovascular Diseases has become one of the most common causes of mortality and morbidity. The most common cardiovascular diseases in North America are coronary artery disease, arrhythmias, peripheral vascular disease, heart failure, and congenital heart defects.

The rising number of cases of renal failure and chronic kidney disease is likely to drive market expansion. In addition, the increased prevalence of chronic liver disease and cirrhosis in North America is expected to fuel market expansion.

The major growth factors for the organ preservation market are increasing incidences of organ failures occurring worldwide due to the high growth of the senior population, as well as various regional authorities providing favorable regulations, organizing initiatives, and creating awareness programs to increase the volume of organ donations and organ transplantation procedures in North America.

Large-scale costs associated with organ transplantation restrict consumers to a smaller consumer base in North America. In contrast, a lack of suitable donors and alternative modes of organ transplantation available, such as developing organs using stem cell procedures, are expected to limit the market's growth in the forecasted period.

The increase in senior citizens in North America will also drive market growth for organ preservation solutions, as the risk of organ failure is higher in this age group.

This research report on the North America Organ Preservation Market has been segmented and sub-segmented into the following categories.

By Preservation Solution:

• UW
• Custodial HTK
• Perfadex

By Transportation Technique:

• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion

By Organ Type:

• Kidneys
• Liver
• lung

By Country:

• the United States
• Canada
• Rest of North America

Geographically, North America dominated the Organ Preservation Market with a 39 percent share. A significant driver driving the organ preservation market during the forecast period is the rising usage of improved medical technologies and increased development by firms involved in organ preservation.

North America led the market in 2022 and is projected to do this shortly. The rising adoption of innovative healthcare technology, the high prevalence of chronic renal disease and heart failure, improved reimbursement rules, and more investments in enhancing healthcare infrastructure are all driving the industry forward.

Individual market affecting factors and changes in market regulation in the United States organ preservation market and Canada organ preservation market are also covered in the national portion of the organ preservation market study, which impacts the market's current and future trends.

KEY MARKET PLAYERS

Some of the Promising Companies dominating the North America Organ Preservation Market Profiled in the Report are Essential Pharmaceuticals (U.S.), Dr Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), and Waters Medical Systems LLC (U.S.).,